The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng‐Hua Wang, Rui‐Hua Xu, Muyan Cai et al.|癌症：英文版|2023Cited by 412
Apatinib Plus Toripalimab (Anti-PD1 Therapy) as Second-Line Therapy in Patients With Advanced Gastric or Esophagogastric Junction Cancer: Results From a Randomized, Open-Label Phase II StudyQing Wei, Jieer Ying, Xiaoqing Xu et al.|The Oncologist|2024Cited by 10